EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
复制标题
DOI：
10.1016/j.jhep.2018.03.018
复制
发表时间：
2018-07-01
影响因子：
25.7
通讯作者：
中科院分区：
文献类型：
--
作者：
据估计，有害使用酒精每年造成约330万人死亡，相当于全球所有死亡人数的近6%。因此，酒精性肝病的有效管理和治疗是一个相关的公共卫生问题。在以下临床实践指南中，将审查酒精相关肝病治疗和管理的最新数据，并提供最新的临床管理建议。(C)2018年欧洲肝脏研究协会。Elsevier B.V.出版，保留所有权利。
The harmful use of alcohol has been estimated to cause approximately 3.3 million deaths every year, corresponding to nearly 6% of all deaths globally. Therefore, the effective management and treatment of alcoholic liver disease is a pertinent public health issue. In the following Clinical Practice Guidelines, the latest data on the treatment and management of alcohol-related liver disease will be reviewed and up to date recommendations for clinical management will be provided. (C) 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.